MedTrace Logo

Fungal Surveillance in Bangladesh

NCT06103331 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2023-11-22

No results posted yet for this study

Summary

This will be an exploratory descriptive study designed to conduct surveillance for the identification of invasive fungal pathogens among hospitalized patients in Bangladesh at two tertiary care acute-level hospitals. including the Dhaka Medical College Hospital, the Dhaka Hospital of icddr,b, and the National Institute of Cancer Research Hospital (NICRH). Respiratory samples, blood, urine, cerebrospinal fluid, surgical wound infection swabs, and other samples including biopsy tissue specimens will be obtained at intensive care units, general medicine and surgery wards, post-operative care, etc. The collected specimens will be sent to the clinical microbiology laboratories of the surveillance hospitals or to the pathology laboratory (biopsy tissue specimens) to test for Aspergillus, Histoplasms, Candida, Pneumocystis, Cryptococcus, and Mucormycetes. The lab. methods will include microscopy, staining, culture, and biochemical tests mainly and if feasible then some specimens may undergo molecular or immunological methods.

Conditions

  • Invasive Fungal Infections

Interventions

OTHER

Invasive Fungal disease surveillance

Management of invasive fungal infection according to pathogen identification and susceptibility report.

Sponsors & Collaborators

  • Centers for Disease Control and Prevention

    collaborator FED

  • Institute of Epidemiology, Disease Control and Research

    collaborator OTHER

  • International Centre for Diarrhoeal Disease Research, Bangladesh

    lead OTHER

Principal Investigators

  • Sayeeda Huq, MBBS,MIPH · International Centre for Diarrheal Diseases Research, Bangladesh

Eligibility

Min Age
0 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-20
Primary Completion
2026-06-01
Completion
2026-09-30

Countries

  • Bangladesh

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06103331 on ClinicalTrials.gov